Baillie Gifford & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $989M | Sell |
3,031,891
-625,716
| -17% | -$204M | 0.74% | 24 |
|
|
2025
Q1 | $988M | Sell |
3,657,607
-382,652
| -9% | -$103M | 0.86% | 26 |
|
|
2024
Q4 | $951M | Sell |
4,040,259
-846,741
| -17% | -$199M | 0.73% | 30 |
|
|
2024
Q3 | $1.34B | Sell |
4,887,000
-1,145,656
| -19% | -$315M | 1.01% | 24 |
|
|
2024
Q2 | $1.47B | Sell |
6,032,656
-590,921
| -9% | -$144M | 1.14% | 23 |
|
|
2024
Q1 | $990M | Sell |
6,623,577
-343,520
| -5% | -$51.3M | 0.77% | 33 |
|
|
2023
Q4 | $1.33B | Sell |
6,967,097
-1,196,042
| -15% | -$229M | 1.06% | 24 |
|
|
2023
Q3 | $1.45B | Sell |
8,163,139
-229,077
| -3% | -$40.6M | 1.32% | 18 |
|
|
2023
Q2 | $1.59B | Sell |
8,392,216
-246,925
| -3% | -$46.9M | 1.36% | 18 |
|
|
2023
Q1 | $1.73B | Sell |
8,639,141
-768,730
| -8% | -$154M | 1.56% | 16 |
|
|
2022
Q4 | $2.24B | Sell |
9,407,871
-106,887
| -1% | -$25.4M | 2.33% | 9 |
|
|
2022
Q3 | $1.9B | Sell |
9,514,758
-453,676
| -5% | -$90.8M | 1.96% | 8 |
|
|
2022
Q2 | $1.45B | Sell |
9,968,434
-171,295
| -2% | -$25M | 1.49% | 15 |
|
|
2022
Q1 | $1.66B | Sell |
10,139,729
-477,022
| -4% | -$77.9M | 1.16% | 24 |
|
|
2021
Q4 | $1.8B | Buy |
10,616,751
+200,967
| +2% | +$34.1M | 0.99% | 27 |
|
|
2021
Q3 | $1.97B | Buy |
10,415,784
+190,925
| +2% | +$36M | 1.03% | 24 |
|
|
2021
Q2 | $1.73B | Buy |
10,224,859
+149,896
| +1% | +$25.4M | 0.84% | 29 |
|
|
2021
Q1 | $1.42B | Buy |
10,074,963
+942,541
| +10% | +$133M | 0.8% | 33 |
|
|
2020
Q4 | $1.19B | Buy |
9,132,422
+240,934
| +3% | +$31.3M | 0.66% | 36 |
|
|
2020
Q3 | $1.29B | Buy |
8,891,488
+242,810
| +3% | +$35.4M | 0.89% | 29 |
|
|
2020
Q2 | $1.28B | Buy |
8,648,678
+236,909
| +3% | +$35.1M | 0.98% | 22 |
|
|
2020
Q1 | $916M | Buy |
8,411,769
+225,046
| +3% | +$24.5M | 0.99% | 26 |
|
|
2019
Q4 | $943M | Sell |
8,186,723
-49,251
| -0.6% | -$5.67M | 0.91% | 23 |
|
|
2019
Q3 | $662M | Buy |
8,235,974
+2,022,504
| +33% | +$163M | 0.75% | 30 |
|
|
2019
Q2 | $451M | Buy |
6,213,470
+528,966
| +9% | +$38.4M | 0.48% | 56 |
|
|
2019
Q1 | $531M | Buy |
5,684,504
+937,654
| +20% | +$87.6M | 0.58% | 42 |
|
|
2018
Q4 | $346M | Buy |
4,746,850
+284,024
| +6% | +$20.7M | 0.45% | 60 |
|
|
2018
Q3 | $391M | Buy |
4,462,826
+230,945
| +5% | +$20.2M | 0.42% | 56 |
|
|
2018
Q2 | $417M | Buy |
4,231,881
+397,668
| +10% | +$39.2M | 0.45% | 51 |
|
|
2018
Q1 | $457M | Buy |
3,834,213
+223,199
| +6% | +$26.6M | 0.54% | 46 |
|
|
2017
Q4 | $459M | Buy |
3,611,014
+205,622
| +6% | +$26.1M | 0.57% | 43 |
|
|
2017
Q3 | $400M | Sell |
3,405,392
-25,924
| -0.8% | -$3.05M | 0.51% | 41 |
|
|
2017
Q2 | $274M | Buy |
3,431,316
+96,805
| +3% | +$7.72M | 0.37% | 60 |
|
|
2017
Q1 | $171M | Buy |
3,334,511
+16,489
| +0.5% | +$845K | 0.25% | 73 |
|
|
2016
Q4 | $124M | Sell |
3,318,022
-50,303
| -1% | -$1.88M | 0.2% | 77 |
|
|
2016
Q3 | $228M | Sell |
3,368,325
-21,927
| -0.6% | -$1.49M | 0.36% | 61 |
|
|
2016
Q2 | $188M | Buy |
3,390,252
+10,317
| +0.3% | +$572K | 0.34% | 62 |
|
|
2016
Q1 | $212M | Buy |
3,379,935
+652,201
| +24% | +$40.9M | 0.37% | 58 |
|
|
2015
Q4 | $257M | Buy |
2,727,734
+2,018,484
| +285% | +$190M | 0.45% | 53 |
|
|
2015
Q3 | $57M | Sell |
709,250
-82,500
| -10% | -$6.63M | 0.11% | 93 |
|
|
2015
Q2 | $94.9M | Sell |
791,750
-231,680
| -23% | -$27.8M | 0.17% | 83 |
|
|
2015
Q1 | $107M | Sell |
1,023,430
-70,000
| -6% | -$7.31M | 0.2% | 79 |
|
|
2014
Q4 | $106M | Sell |
1,093,430
-97,500
| -8% | -$9.46M | 0.21% | 79 |
|
|
2014
Q3 | $93M | Hold |
1,190,930
| – | – | 0.2% | 76 |
|
|
2014
Q2 | $75.2M | Buy |
1,190,930
+118,130
| +11% | +$7.46M | 0.16% | 83 |
|
|
2014
Q1 | $72M | Buy |
1,072,800
+179,700
| +20% | +$12.1M | 0.17% | 84 |
|
|
2013
Q4 | $57.5M | Buy |
893,100
+140,100
| +19% | +$9.01M | 0.14% | 88 |
|
|
2013
Q3 | $48.2M | Sell |
753,000
-147,900
| -16% | -$9.47M | 0.12% | 90 |
|
|
2013
Q2 | $27.9M | Buy |
+900,900
| New | +$27.9M | 0.08% | 102 |
|